The Fast‐Growing Field of Cancer Immunotherapy Based on Aggregation‐Induced Emission
Aggregate · 2025-11 · 6 (11)
DOI: 10.1002/agt2.70189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aggregate, online erschienen am 23.10.2025. Verfasst von Zhijie Lin und 5 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Science and Technology Foundation of Shenzhen City.
Abstract (Originalsprache)
Cancer immunotherapy is a groundbreaking treatment that utilizes the body's immune system to fight against cancers. Despite the clinical application of several immunotherapeutic agents, challenges persist, including limited patient responsiveness and adverse events stemming from immune activation, which constrain overall efficacy. Recent advances in aggregation‐induced emission luminogens (AIEgens) have propelled innovations in nanomedicine. Traditional fluorophores often suffer from aggregation‐caused quenching (ACQ). On the contrary, AIEgens exhibit intense emission upon aggregation, alongside advantageous properties, including minimal background interference, high photostability, as well as multifunctional therapeutic capabilities (such as photothermal therapy, PTT; photodynamic therapy, PDT; and sonodynamic therapy, SDT). Moreover, their exceptional biocompatibility positions them as promising agents for tumor immunotherapy. This review offers a thorough examination of how AIEgens enhance antitumor immunity through mechanisms such as immunogenic cell death (ICD), apoptosis, and pyroptosis, which collectively activate immune cells, reprogram the immunosuppressive tumor microenvironment (TME), suppress tumor proliferation, and mitigate metastasis and recurrence. By highlighting these advances, we aim to stimulate further research into the development of next‐generation AIEgens for broader immunological applications and to promote their clinical translation.
Förderung
- National Key Research and Development Program of China
- Science and Technology Foundation of Shenzhen City
Zitieren
APA
Lin, Z., He, T., Kang, M., Xie, W., Wang, D., & Tang, B. Z. (2025). The Fast‐Growing Field of Cancer Immunotherapy Based on Aggregation‐Induced Emission. Aggregate, 6(11). https://doi.org/10.1002/agt2.70189
Vancouver
Lin Z, He T, Kang M, Xie W, Wang D, Tang BZ. The Fast‐Growing Field of Cancer Immunotherapy Based on Aggregation‐Induced Emission. Aggregate. 2025;6(11). doi:10.1002/agt2.70189
BibTeX
@article{Lin2025,
author = {Lin, Zhijie and He, Tingting and Kang, Miaomiao and Xie, Wei and Wang, Dong and Tang, Ben Zhong},
title = {The Fast‐Growing Field of Cancer Immunotherapy Based on Aggregation‐Induced Emission},
journal = {Aggregate},
year = {2025},
volume = {6},
number = {11},
doi = {10.1002/agt2.70189}
}
EUVIMED